Ortin Laboratories Ltd

Ortin Labs. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Ortin Laboratories Ltd

₹ 20.0 2.05%
24 Apr - close price
ortinlabsindia.com BSE: 539287 NSE : ORTINLAB
About

Incorporated in 1986, Ortin Laboratories Ltd is engaged in the manufacturing and trading of Pharmaceuticals, Drugs and Intermediates.

Key Points

Product Portfolio:
a) Formulations:[1] Anti Diabetics, Anti Allergics, Anti Anginal & Cardio Vascular, Sedatives & Tranquillizers, Analgesics & Antipyretics Anti Helmenthetics, Anti-fungal, Anti Biotics-Quinolones, Anti Biotic-Penicillin, Chemo Therapeutics, Cephalosporins, Macrolides, Anti-ulcerants & Antacids, Anti-spasmodic, Calcium preparations, Iron preparations, Gynec, Anti -Arthritic Drugs, Protein supplements, Enzymes, Vitamins, Psychiatry, Appetizers, Anti-Retroviral
b) API Intermediates:[2] Anti retro viral, Anti Diabetics, Antifungal, Antacids & Anti ulcerant, Analgesics & Antipyretics, Anti - Biotic, Anti malarial, Fine chemicals, Grignard & alkali metal products
c) Merchant Export Trading:[3]
Company supplies pharmaceutical formulations comprising tablets, capsules, liquid orals, ear
drops, nasal drops, ointments, liquid injections, sterile dry powder injections, pharmaceutical veterinary tablets, dry syrups, sterile powder.

Website BSE NSE
  • Market Cap ₹ 16.3 Cr.
  • Current Price ₹ 20.0
  • High / Low ₹ 30.4 / 16.2
  • Stock P/E
  • Book Value ₹ 12.0
  • Dividend Yield 0.00 %
  • ROCE 1.80 %
  • ROE -0.64 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -40.4% over past five years.
  • Promoter holding is low: 7.36%
  • Company has a low return on equity of 1.21% over last 3 years.
  • Company might be capitalizing the interest cost
  • Company has high debtors of 208 days.
  • Promoter holding has decreased over last 3 years: -27.5%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
51.77 1.76 1.98 2.29 1.66 2.45 2.62 0.79 1.17 1.49 1.57 0.27 0.14
49.61 1.55 1.61 2.00 1.65 2.59 2.41 1.01 0.55 1.52 1.39 1.17 2.74
Operating Profit 2.16 0.21 0.37 0.29 0.01 -0.14 0.21 -0.22 0.62 -0.03 0.18 -0.90 -2.60
OPM % 4.17% 11.93% 18.69% 12.66% 0.60% -5.71% 8.02% -27.85% 52.99% -2.01% 11.46% -333.33% -1,857.14%
0.12 0.05 0.00 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.86 0.19 0.18 0.19 0.19 0.24 0.10 0.09 0.10 0.12 0.11 0.15 0.14
Depreciation 0.53 0.07 0.07 0.07 -0.07 0.23 0.07 0.07 0.07 0.03 0.06 0.06 0.06
Profit before tax 0.89 0.00 0.12 0.07 -0.11 -0.61 0.04 -0.38 0.45 -0.18 0.01 -1.11 -2.80
Tax % 32.58% 25.00% 28.57% 18.18% 24.59% 1,150.00% 121.05% 0.00% 5.56% 0.00% -1.80% 0.71%
0.60 0.80 0.09 0.05 -0.09 -0.45 -0.43 0.08 0.46 -0.18 0.02 -1.12 -2.79
EPS in Rs 0.36 0.98 0.11 0.06 -0.11 -0.55 -0.53 0.10 0.57 -0.22 0.02 -1.38 -3.43
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
90.46 74.74 67.00 60.29 62.72 61.57 79.63 167.51 197.36 8.16 8.23 6.00 3.47
83.53 68.17 60.90 53.80 56.83 56.12 74.22 160.83 191.66 6.92 7.85 5.47 6.82
Operating Profit 6.93 6.57 6.10 6.49 5.89 5.45 5.41 6.68 5.70 1.24 0.38 0.53 -3.35
OPM % 7.66% 8.79% 9.10% 10.76% 9.39% 8.85% 6.79% 3.99% 2.89% 15.20% 4.62% 8.83% -96.54%
0.26 0.24 0.81 0.00 0.57 0.32 0.45 0.13 0.18 0.05 0.19 0.01 0.00
Interest 3.28 3.55 3.72 3.52 3.42 2.94 3.49 3.22 3.21 0.87 0.81 0.40 0.52
Depreciation 1.33 1.40 1.51 1.64 1.65 1.70 1.69 1.75 1.96 0.29 0.29 0.25 0.21
Profit before tax 2.58 1.86 1.68 1.33 1.39 1.13 0.68 1.84 0.71 0.13 -0.53 -0.11 -4.08
Tax % 50.78% 41.40% 29.17% 32.33% 41.01% 55.75% 0.00% 30.43% 181.69% -623.08% 24.53% 18.18%
1.28 1.09 1.19 0.90 0.83 0.50 0.68 1.28 -0.56 0.95 -0.40 -0.09 -4.07
EPS in Rs 0.76 0.64 0.70 0.53 0.49 0.30 0.40 0.76 -0.33 1.17 -0.49 -0.11 -5.01
Dividend Payout % 66.17% 38.85% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -22%
5 Years: -40%
3 Years: -69%
TTM: -51%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 23%
TTM: -1097%
Stock Price CAGR
10 Years: %
5 Years: 7%
3 Years: -14%
1 Year: 3%
Return on Equity
10 Years: 3%
5 Years: 1%
3 Years: 1%
Last Year: -1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 16.94 16.94 16.94 16.94 16.94 16.94 16.94 16.94 16.94 8.13 8.13 8.13 8.13
Reserves 3.24 3.84 5.02 5.50 6.33 6.46 7.14 8.15 6.88 3.22 2.83 2.73 1.63
13.08 17.92 18.68 20.96 20.85 17.34 17.34 19.47 19.57 6.94 6.14 6.45 6.01
49.80 34.80 31.93 23.87 21.22 20.79 32.24 60.53 73.13 2.97 3.61 3.89 2.46
Total Liabilities 83.06 73.50 72.57 67.27 65.34 61.53 73.66 105.09 116.52 21.26 20.71 21.20 18.23
23.85 24.77 23.90 21.83 21.63 20.69 20.03 21.29 22.45 14.38 14.21 13.96 13.84
CWIP 0.00 0.00 0.00 0.00 0.00 0.35 0.40 0.53 0.43 0.43 0.43 0.43 0.43
Investments 0.03 0.03 0.03 0.03 0.03 0.07 0.08 0.08 0.07 0.00 0.00 0.00 0.00
59.18 48.70 48.64 45.41 43.68 40.42 53.15 83.19 93.57 6.45 6.07 6.81 3.96
Total Assets 83.06 73.50 72.57 67.27 65.34 61.53 73.66 105.09 116.52 21.26 20.71 21.20 18.23

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
0.29 -1.66 -1.76 -1.38 0.52 1.94 1.56 6.52 3.30 18.03 2.15 -0.25
-2.23 -2.08 -0.02 0.22 -0.86 -1.26 -0.90 -3.27 -3.09 0.07 -0.13 0.01
1.79 4.70 0.97 1.73 0.27 -0.82 0.07 -2.89 -1.33 -9.86 -0.47 0.90
Net Cash Flow -0.15 0.96 -0.81 0.58 -0.07 -0.14 0.73 0.37 -1.12 8.25 1.55 0.66

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 176.97 134.10 116.69 103.77 53.13 90.35 100.15 82.43 68.71 174.90 143.69 208.05
Inventory Days 60.92 102.80 162.92 192.30 148.72 158.21 152.21 100.07 117.80 169.10 136.29 279.94
Days Payable 250.38 199.45 197.95 151.09 24.82 108.10 143.09 145.12 155.80 123.82 61.88 166.89
Cash Conversion Cycle -12.50 37.45 81.66 144.97 177.04 140.45 109.28 37.38 30.70 220.17 218.10 321.10
Working Capital Days 35.55 56.94 86.07 118.60 104.81 126.92 108.68 48.94 38.38 158.79 86.93 168.51
ROCE % 22.50% 14.90% 13.08% 12.07% 10.92% 9.57% 9.44% 11.77% 8.94% 3.24% 1.58% 1.80%

Shareholding Pattern

Numbers in percentages

18 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
15.68% 15.68% 15.68% 15.68% 15.68% 15.68% 15.68% 21.51% 7.36% 7.37% 7.36% 1.23%
84.32% 84.32% 84.32% 84.32% 84.32% 84.32% 84.31% 78.49% 92.63% 92.64% 92.64% 98.76%
No. of Shareholders 12,30211,94712,81912,66212,57112,44912,78112,58512,18111,83612,31412,192

Documents

Announcements

Annual reports